Robert W. Baird has recently initiated Dyne Therapeutics Inc (DYN) stock to Outperform rating, as announced on December 13, 2024, according to Finviz. Earlier, on November 26, 2024, RBC Capital Mkts ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...